1st Quarter - Termination
RUBICON ADVISORS, LLC for AVET PHARMACEUTICALS
Client
Income
$30,000
Expenses
—
Terminated
Jan 1, 2022
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report | Apr 20, 2022 | $30,000 | Replaced |
| 1st Quarter - Termination (this page) | Jul 21, 2024 | $30,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
GENERIC DRUG PRICING,HOUSE COMMITTEE ON OVERSIGHT,GOVERNMENT REFORM, FOOD AND DRUG ADMINISTRATION AND COVID-19 DRUG SHORTAGES
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM BURKE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.